Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

SCCT President Ed Nicol, MD, explains key trends trends in cardiac CT imaging at the 2023 meeting. #SCCT #SCCT23 #SCCT2023

Key trends and takeaways in cardiac CT at SCCT 2023

Several key trends at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography were outlined by society President Ed Nicol, MD, including AI, reimbursement issue, business management discussions, and a growing interest in cardiac CT leading to record attendance this year.

The team that implanted the first TaurusTrio TAVR valve at Beijing An Zhen Hospital, Capital Medical University in July 2023.

Chinese made version of JenaValve TAVR device implanted in first patient

The first patient was enrolled in a multicenter clinical trial for the TaurusTrio transcatheter aortic valve replacement system, used for aortic regurgitation.

HeartFlow's RoadMap technology where AI reads the image in a first pass to highlight areas of interest with for the radiologist or cardiologist on coronary CT scan. The technology was shown to reduce reading time by 25%.

Three studies show value of AI to speed cardiac CT reads and soft plaque evaluation 

AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

FDA clears new AI to guide point-of-care cardiac ultrasound exams

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

Atrial fibrillation after TAVR linked to much higher risk of death, heart failure

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

Matt Martinez, MD, Morristown Medical Center HCM program, explains how hypertrophic cardiomyopathy patient management is changing.

Exercise plays a key part in HCM management

Matthew Martinez, MD, detailed the many ways HCM care management is changing during an exclusive interview at ASE 2023.

money business cash flow dollar

PaceMate gains a key investor in its heart monitoring technology

Lead Edge Capital is a well-known tech investor that has previously worked with such groups as Spotify, Duo Security and Toast.

Video of Maddie Jankowski explaining sonographer highlights and trends at the American Society of Echo (ASE) 2023 meeting.

The rise of AI and other key takeaways for sonographers at ASE 2023

Cardiac sonographer Maddie Jankowski, BS, ACS, RDCS, joined us to explore key trends and updates for sonographers from ASE 2023 in National Harbor, Maryland. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.